Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000
Sudden Hearing Loss as the Initial Monosymptom of Multiple Sclerosis
Neurol 43:2703-2705, Drulovic,B.,et al, 1993
Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989
Neurofibromatosis 2 (Bilateral Acoustic Neuro-fibromatosis)
NEJM 318:684-688, Martuza,R.L.&Eldridge,R., 1988
Evoked Potentials in Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 45:1014-1016, Pakalnis,A.,et al, 1988
Locked-In Syndrome:A Review of 139 Cases
Stroke 17:758-764, Patterson,J.R.&Grabois,M., 1986
Hearing Loss in Multiple Sclerosis
Arch Neurol 40:33-35, Daugherty,W.T.,et al, 1983
Multiple Sclerosis After Age 50
Neurol 33:1537-1544, Noseworthy,J.,et al, 1983
Evoked Potentials In Clinical Medicine, (First of Two Parts)
NEJM 306:1140-1150, Chiappa,K.H.,et al, 1982
Multimodality Evoked Potentials & Blink Reflex in Multiple Sclerosis
Neurol 31:138-144, Khoshbin,S.,et al, 1981
Brain Stem Auditory Evoked Responses
Arch Neurol 36:81-87, Chiappa,K.H.,et al, 1979